5240 articles
Maria Maccecchini, PhD, CEO of Annovis Bio discusses the company's lead program ANVS401 that has shown that it lowers levels of neurotoxic proteins f...
Rob Etherington, CEO at Clene Nanomedicine discusses the company's lead drug candidate CNM-Au8, a catalytically active gold nanotherapeutic that drives ...
Carol Routledge, Chief Medical and Scientific Officer at Small Pharma discusses the company's clinical trials with N, N-dimethyltryptamine (DMT), a natu...
Brian Dugan, Senior Director, Head of Enterprise Genomics and NGS Product Management at QIAGEN discusses the more than three billion biological samples ...
Vivek Subbiah, MD, Associate Professor in the Investigational Cancer Therapeutics department and Center Clinical Medical Director of the Clinical Center...
Hans Eriksson, Chief Clinical Development Officer discusses HMNC Brain Health, the first and only company taking the "precision" approach to psychiatry,...
Ben Chew discuss two abstracts made available virtually by the World Congress of Endourology (WCET) titled " Identifying Predictors of Sepsis Post-Urete...
Abi Sundaramoorthy, Executive Vice President, Clinical Enterprise, Somatus, a kidney care company discusses the collaboration with Anthem to find kidney...
Ronan Levy, Co-founder of Field Trip Health, a global leader in the development and delivery of psychedelic therapies, discusses what to look for before...
Janssen Immunology has a track record of defining and redefining the treatment of immune-mediated disease. Learn more on Health Professional Radio.